ENTITY

Recordati (REC IM)

27
Analysis
Health Care • Italy
Recordati is an international pharmaceutical group engaged in the research, development, manufacturing, and marketing of pharmaceuticals. The company focuses on specialty and primary care products, including treatments for cardiovascular, urological, and gastrointestinal conditions, as well as a dedicated rare disease business unit. Recordati was founded in 1926 and is headquartered in Milan, Italy.
more
bullish•Recordati
•07 Oct 2024 11:15

Recordati - ESG Report - Lucror Analytics

Lucror Analytics' ESG Scores are based on a 3-tiered scale and are adjusted for Controversies (if applicable). We assess Recordati's ESG as...

Logo
317 Views
Share
bearish•ams AG
•27 Sep 2024 18:30

Europe HY Trade Book - September 2024 - Lucror Analytics

The Europe HY Trade Book for September 2024 includes current trade recommendations drawn from our European HY coverage universe, along with...

Logo
565 Views
Share
bearish•ams AG
•29 Aug 2024 03:00

Europe HY Trade Book - August 2024 - Lucror Analytics

The Europe HY Trade Book for August 2024 includes current trade recommendations drawn from our European HY coverage universe, along with...

Logo
230 Views
Share
bearish•Evoke
•07 Dec 2023 19:30

Europe HY Trade Book - December 2023 - Lucror Analytics

The Europe HY Trade Book for December 2023 includes current trade recommendations drawn from our European HY coverage universe, along with...

Logo
680 Views
Share
bearish•Evoke
•24 Oct 2023 17:15

Europe HY Trade Book - October 2023 - Lucror Analytics

The Europe HY Trade Book for October 2023 includes current trade recommendations drawn from our European HY coverage universe, along with...

Logo
505 Views
Share
x